vendredi 26 juillet 2019

Onco Actu du 26 juillet 2019


1. BIOLOGIE



Flower power as human cancer cells compete with normal cells [Nature]











1.4 BIOLOGIE - TECHNOS



A GPS-like System for Single-Cell Analysis [NIH Director's Blog]











2.5 ETIOLOGIE - GÈNES



Germline BRCA2 Mutations Linked to Pediatric Non-Hodgkin Lymphoma Risk [Genome Web]











Inherited BRCA2 mutations linked to increased risk of childhood lymphoma [St. Jude Children's Research Hospital]










3.1.1 PRÉVENTION - TABAC - E-CIGS



Want to quit smoking? Try an e-cigarette [Harvard Gazette]











Juul Targeted Schools, Camps and Youth Programs, House Panel Claims [NY Times]











U.S. lawmakers grill e-cigarette maker Juul over efforts targeted at schoolchildren [Reuters]











3.3 PRÉVENTION - VACCINS



The HPV vaccine is on trial as anti-vaxxers mobilize against effective cancer prevention [NBC]











4.2 DÉP., DIAG. & PRONO. - GÉNOME



Five million Britons to be offered free personalised DNA reports [The Telegraph]











Accuracy of Genotyping Chips Called into Question [The Scientist]










5. TRAITEMENTS



Laser-Based Device Detects and Kills Melanoma Cells in the Blood, Study Finds [NCI]










5.1 TRAITEMENTS - PRÉ-CLINIQUE



Cancer drug data release set to power next wave of therapeutic discovery [Sanger Institute]










PARP inhibitors sometimes work beyond BRCA-mutations, researchers may finally know why [EndPoints]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



Study in Mice Advances Combination Immune Therapy for Ovarian Cancer [Johns Hopkins]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



How Scientists Built a ‘Living Drug’ to Beat Cancer [Wired]











5.12.4 IMMUNOTHÉRAPIES - ESSAIS



Favorable Five-Year Survival Reported For Patients With Advanced Cancer Treated With The Immunotherapy Drug Nivolumab [Johns Hopkins]











5.12.5 IMMUNOTHÉRAPIES - PHARMA



Can BMS parlay its surprise 'win and a miss' in first-line lung cancer into a net gain? [Fierce Pharma]











5.17 TRAITEMENTS - RADIOTHÉRAPIE



Updated PORTEC-3 Analysis Shows Improved Survival With Chemoradiotherapy Versus Radiotherapy Alone [ESMO]











5.2 PHARMA



GSK's cancer pipeline doubles as Barron's plan takes effect [Fierce Biotech]











5.3 TRAITEMENTS - FDA, EMA, NICE...



FDA’s Woodcock weighs in on role of NIH in drug development [EndPoints]











5.4 TRAITEMENTS - ECONOMIE



Innovative treatment for gynaecological cancers approved for Cancer Drugs Fund [NICE]










Ovarian cancer drug olaparib 'can delay disease in newly diagnosed' [BBC News]











ICR calls for wider gene testing in ovarian cancer after approval of olaparib earlier in treatment for women with BRCA mutations [Institute of Cancer Research]











Game-changing ovarian cancer drug which extends survival by three years gets NHS green light [The Telegraph]











6.7.1 IA/BIOINFORMATIQUE



AI tool identifies cancer outcomes using radiology reports [Dana-Farber Cancer Institute]











6.8 COMMUNICATION



Fake news exists even in the fight against cancer [Anticancer Fund]